• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅内动脉瘤性蛛网膜下腔出血后继发脑积水。

Hydrocephalus after aneurysmal subarachnoid hemorrhage.

机构信息

Division of Neurosurgery, University of North Carolina School of Medicine, 170 Manning Drive, Campus Box #7060, Chapel Hill, NC 27599-7060, USA.

出版信息

Neurosurg Clin N Am. 2010 Apr;21(2):263-70. doi: 10.1016/j.nec.2009.10.013.

DOI:10.1016/j.nec.2009.10.013
PMID:20380968
Abstract

Hydrocephalus is a common and potentially devastating complication of aneurysmal subarachnoid hemorrhage (SAH). Its incidence is approximately 20% to 30%, and its onset can be acute, within 48 hours after SAH, or rarely chronic, occurring in a delayed fashion weeks and even months after the hemorrhage. Early recognition of its signs and symptoms and accurate interpretation of computed tomography (CT) studies are important for the management of patients with SAH. Clinically, a poor neurologic grade has the highest correlation with an increased incidence of hydrocephalus. Radiographically, the bicaudate index on CT studies has emerged as the best marker of this condition. Although further studies are needed to understand the complex pathophysiology of this condition, hydrocephalus after SAH can be treated effectively using current technology.

摘要

脑积水是蛛网膜下腔出血(SAH)的一种常见且潜在严重的并发症。其发病率约为 20%至 30%,发病时间可分为急性,即在 SAH 后 48 小时内,或罕见的慢性,在出血后数周甚至数月延迟发生。早期识别其体征和症状,并准确解读计算机断层扫描(CT)研究对 SAH 患者的治疗非常重要。临床上,神经功能分级较差与脑积水发生率增高有最高的相关性。影像学上,CT 研究中的双尾指数已成为该疾病的最佳标志物。尽管需要进一步研究来了解这种情况的复杂病理生理学,但目前的技术可以有效地治疗 SAH 后发生的脑积水。

相似文献

1
Hydrocephalus after aneurysmal subarachnoid hemorrhage.颅内动脉瘤性蛛网膜下腔出血后继发脑积水。
Neurosurg Clin N Am. 2010 Apr;21(2):263-70. doi: 10.1016/j.nec.2009.10.013.
2
Prognosis and treatment of acute hydrocephalus following aneurysmal subarachnoid haemorrhage.颅内动脉瘤性蛛网膜下腔出血后急性脑积水的预后和治疗。
J Clin Neurosci. 2012 May;19(5):669-72. doi: 10.1016/j.jocn.2011.06.032. Epub 2012 Feb 22.
3
Risk of rebleeding after treatment of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血患者急性脑积水治疗后再出血的风险
Stroke. 2007 Jan;38(1):96-9. doi: 10.1161/01.STR.0000251841.51332.1d. Epub 2006 Nov 22.
4
Extent of acute hydrocephalus after subarachnoid hemorrhage as a risk factor for poor functional outcome.蛛网膜下腔出血后急性脑积水的程度作为功能预后不良的危险因素。
Neurol Res. 2013 Mar;35(2):107-10. doi: 10.1179/1743132812Y.0000000122.
5
Chronic hydrocephalus after neurosurgical and endovascular treatment of ruptured intracranial aneurysms.颅内破裂动脉瘤神经外科和血管内治疗后的慢性脑积水
Acta Radiol. 2008 Jul;49(6):680-6. doi: 10.1080/02841850802050754.
6
Predictors of long-term shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage. Clinical article.预测动脉瘤性蛛网膜下腔出血后长期依赖分流的脑积水的因素。临床文章。
J Neurosurg. 2010 Oct;113(4):774-80. doi: 10.3171/2010.2.JNS09376.
7
Factors leading to hydrocephalus after aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后导致脑积水的因素。
Minim Invasive Neurosurg. 2003 Dec;46(6):344-8. doi: 10.1055/s-2003-812500.
8
Acute hydrocephalus following aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后的急性脑积水
Can J Neurol Sci. 1996 Feb;23(1):40-5. doi: 10.1017/s0317167100039160.
9
Factors leading to hydrocephalus after aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后导致脑积水的因素。
Neurol Neurochir Pol. 2000;34(6 Suppl):56-60.
10
CT evaluation of lateral ventricular dilatation after subarachnoid hemorrhage: baseline bicaudate index values [correction of balues].蛛网膜下腔出血后侧脑室扩张的CT评估:基线双尾状核指数值[校正值]
Neurol Res. 2013 Mar;35(2):103-6. doi: 10.1179/1743132812Y.0000000121. Epub 2012 Dec 26.

引用本文的文献

1
The Effect of Fibulin-5 on Hydrocephalus After Subarachnoid Hemorrhage in Mice.纤连蛋白-5对小鼠蛛网膜下腔出血后脑积水的影响。
Int J Mol Sci. 2025 Aug 26;26(17):8259. doi: 10.3390/ijms26178259.
2
Prognostic factors in aneurysmal subarachnoid hemorrhage with poor initial clinical grade.初始临床分级较差的动脉瘤性蛛网膜下腔出血的预后因素
Front Neurol. 2025 Apr 2;16:1536643. doi: 10.3389/fneur.2025.1536643. eCollection 2025.
3
Thrombolysis for aneurysmal subarachnoid haemorrhage.动脉瘤性蛛网膜下腔出血的溶栓治疗
Cochrane Database Syst Rev. 2025 Jan 17;1(1):CD013748. doi: 10.1002/14651858.CD013748.pub2.
4
Normal Pressure Hydrocephalus in Adult Mice Causes Gait Impairment, Cognitive Deficits, and Urinary Frequency with Incontinence.成人型正常颅压脑积水导致步态障碍、认知障碍和伴有失禁的排尿频率增加。
eNeuro. 2024 Nov 26;11(11). doi: 10.1523/ENEURO.0412-24.2024. Print 2024 Nov.
5
OxyHbMeter-a novel bedside medical device for monitoring cell-free hemoglobin in the cerebrospinal fluid-proof of principle.氧合血红蛋白测定仪——一种用于监测脑脊液中游离血红蛋白的新型床边医疗设备——原理验证
Front Med Technol. 2024 Apr 11;6:1274058. doi: 10.3389/fmedt.2024.1274058. eCollection 2024.
6
A comparison of ventricular volume and linear indices in predicting shunt dependence in aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血中预测分流依赖时心室容积与线性指标的比较。
World Neurosurg X. 2023 Mar 17;19:100181. doi: 10.1016/j.wnsx.2023.100181. eCollection 2023 Jul.
7
White Matter Injury: An Emerging Potential Target for Treatment after Subarachnoid Hemorrhage.脑白质损伤:蛛网膜下腔出血后治疗的新靶点
Oxid Med Cell Longev. 2023 Feb 7;2023:3842493. doi: 10.1155/2023/3842493. eCollection 2023.
8
Risk factors and predictive models of poor prognosis and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage complicated with hydrocephalus.动脉瘤性蛛网膜下腔出血合并脑积水时预后不良及迟发性脑缺血的危险因素和预测模型。
Front Neurol. 2022 Oct 24;13:1014501. doi: 10.3389/fneur.2022.1014501. eCollection 2022.
9
Clinical Comparison of FD-CT and MS-CT in Aneurysmal Subarachnoid Haemorrhage: A Single Center Experience.FD-CT与MS-CT在动脉瘤性蛛网膜下腔出血中的临床比较:单中心经验
Diagnostics (Basel). 2022 Oct 9;12(10):2443. doi: 10.3390/diagnostics12102443.
10
Non-adjustable gravitational valves or adjustable valves in the treatment of hydrocephalus after aneurysmal subarachnoid hemorrhage patients?非调节性重力阀与可调压阀在颅内动脉瘤性蛛网膜下腔出血后脑积水患者中的治疗作用比较
Acta Neurochir (Wien). 2022 Nov;164(11):2867-2873. doi: 10.1007/s00701-022-05361-0. Epub 2022 Sep 23.